Association of Polygenic Risk for Schizophrenia and DNA Methylation in the Brain

Published 24/09/2024

Background and Importance

Schizophrenia is a complex psychiatric disorder with both genetic and environmental influences. Recent studies have pointed to the role of epigenetics, particularly DNA methylation, in the regulation of gene expression associated with the disorder. This peer-reviewed study, published in Translational Psychiatry, investigates how polygenic risk for schizophrenia (the cumulative effect of multiple genetic variants) influences DNA methylation in the brain.

By examining this relationship, the study aims to provide insights into how genetic risk translates into epigenetic changes that may affect brain function and increase schizophrenia susceptibility.

What Was Studied?

The researchers analysed DNA methylation patterns in post-mortem brain tissue samples from 526 individuals, some with schizophrenia and others as controls. They focused on how a person’s polygenic risk score (PRS) for schizophrenia—a measure of their overall genetic risk based on multiple genetic variants—correlated with methylation levels at different sites across the genome.

The key areas of study included:

• Polygenic Risk for Schizophrenia (PRS): How the cumulative genetic risk, as calculated from a combination of variants, relates to methylation patterns.
• DNA Methylation: Changes in methylation patterns in specific regions of the brain were examined to identify any associations with schizophrenia risk.
• Functional Implications: The potential biological significance of the methylation changes in relation to schizophrenia pathology was also explored.

Key Findings

1. PRS and Methylation Correlation

The study found significant correlations between an individual’s polygenic risk for schizophrenia and DNA methylation at various loci in the brain. Individuals with higher PRS scores exhibited distinct methylation patterns compared to those with lower genetic risk, suggesting that the epigenome may mediate the effects of genetic risk on brain function.

2. Specific Loci and Pathways Affected

The researchers identified several methylation sites that were significantly associated with polygenic risk for schizophrenia. Many of these sites were located near genes involved in neuronal development, synaptic function, and other brain processes critical to schizophrenia pathology.

3. Gene Expression Implications

Methylation changes were linked to alterations in gene expression, particularly in genes related to brain development and function. This suggests that polygenic risk for schizophrenia might influence brain function through epigenetic modifications, potentially contributing to the development of the disorder.

4. Environmental Interactions

While the study focused on genetic risk, it also emphasized that environmental factors might interact with genetic predisposition through epigenetic mechanisms like methylation. This dual influence of genes and environment is critical in understanding the full complexity of schizophrenia risk.

Study Strengths and Limitations

One of the study’s major strengths is its large sample size and detailed analysis of post-mortem brain tissue, which provides direct insights into the brain's molecular processes. Additionally, the use of polygenic risk scores allows for a comprehensive analysis of genetic risk rather than focusing on single gene variants.

However, the study is limited by its observational nature, meaning it can only demonstrate associations, not causality, between polygenic risk and methylation patterns. Furthermore, the use of post-mortem tissue provides a snapshot in time, which may not fully capture the dynamic nature of methylation changes over the course of the disease.

Why This Matters

This study is significant because it bridges the gap between genetic risk and brain function, offering a potential explanation for how genetic risk factors for schizophrenia might manifest in the brain through epigenetic changes. By identifying specific methylation sites associated with polygenic risk, the study provides new targets for future research into the biological mechanisms underlying schizophrenia.

For the general public, this research highlights the importance of understanding how both genetics and epigenetics contribute to mental health disorders like schizophrenia. In the long term, this knowledge could lead to the development of more personalized treatments that target these specific epigenetic changes, offering hope for more effective interventions for schizophrenia and similar psychiatric conditions.

Conclusion of Study

This study concludes that polygenic risk for schizophrenia is significantly associated with distinct DNA methylation patterns in the brain, particularly at genes related to neuronal development and brain function. These findings suggest that epigenetic modifications may mediate the effects of genetic risk, potentially contributing to schizophrenia pathology. The study provides a foundation for further research into the interaction between genetic and epigenetic factors in schizophrenia, with potential implications for the development of targeted therapies.

Back